Skip Navigation
  • Dana-Farber Cancer Care Collaborative

    Dana-Farber/Brigham and Women's Cancer Care Collaborative

    Both the Dana-Farber Cancer Care Collaborative and the Dana-Farber/Brigham and Women's Cancer Care Collaborative serve a select group of hospitals that have demonstrated a commitment to excellence by meeting a wide range of standards and best practices in adult medical and/or radiation oncology.

    To certify a hospital's membership, Dana-Farber clinicians and other specialists conduct an extensive and rigorous review of the hospital's oncology practices and procedures, including:

    • Patient safety protocols
    • Nursing and pharmacy practices
    • Chemotherapy administration
    • Information systems

    Following review of their oncology operations, Collaborative members agree to implement key recommendations in order to meet Dana-Farber standards.

    Benefits of Collaborative membership

    Dana-Farber Collaborative membership enhances educational opportunities for member hospitals' staffs; offers opportunities for members to consult with medical specialists at Dana-Farber in Boston; and provides members with expedited access to Dana-Farber's main campus in Boston for their patients with complex cancers. Members can also take advantage of access to Dana-Farber support services, such as on-site specialty second opinion clinics, clinical trials, tumor board conferences, and physician lectures.

    Dana-Farber is not responsible for the care provided at these locations.

    Members of the Dana-Farber Cancer Care Collaborative — Adult Medical Oncology

    Members of the Dana-Farber/Brigham and Women's Cancer Care Collaborative — Adult Medical and Radiation Oncology

    Dana-Farber Cancer Institute and Lifespan Cancer Institute Strategic Alliance

    Dana-Farber Cancer Institute and the Lifespan Cancer Institute in Rhode Island have created a strategic alliance to advance cancer treatment and research. Dana-Farber and Lifespan will support the expansion of clinical trials, access for Lifespan physicians to cancer-specific disease expertise for complex cases, and the launch of a new program to coordinate the treatment of bone marrow transplant patients, with transplants provided in Boston at Dana-Farber and care surrounding the transplant provided at Lifespan Cancer Institute in Providence. The two organizations will share patient information through their respective cancer-specific electronic health record systems and will use the same clinical trials management platform, resulting in better care coordination.

    Strategic alliance member

    Lifespan Cancer Institute, Rhode Island